All News

Chronic disease patients are more compliant when Rx co-payments decrease.

AAHomecare supports Medicare anti-fraud measures.

CMS announces second round of Medicare DMEPOS competitive bidding program.

FDA warns seven pharmacies that the claims they have made for their bioidentical hormones are unsupported.

William Shields, named CEO of Artomick, a medication management and technology company.

FDA issues warning for bisphosphonates.

According to Consumers Union, drug prices rose at 75% of the Medicare Part D prescription drug plans.

The Centers for Medicare & Medicaid Services proposes a rule to reduce premiums for low-income subsidized patients.

EMHS, PhRMA partner to improve access to medicine in eastern Maine.

Home Diagnostics signs exclusive co-brand agreement with Rite Aid.

NACDS supports FDA toll- free number for reporting adverse events requirement.

NACDS Foundation awards $140,000 in grants to community pharmacy.

Major drugstore chains report weak December sales.

FDA releases new study findings for ESA use in cancer patients.

Medication therapy management opportunities expand in Ohio.

Major drugstore chains report weak December sales.

NACDS Foundation increases pharmacy student scholarships.

Florida and Wyoming officials explore real-time monitoring of prescription medications.

Drug Topics' poll finds pharmacists against Mevacor going OTC.

Prescription drug samples rarely go to poor and uninsured according to Harvard study.

Florida and Wyoming officials explore real-time monitoring of prescription medications.

Ferring fertility program expanded

New rule requires pharmacies to provide patients with a toll-free number to report adverse events.

Drug Topics launches time capsule for future pharmacists

Pharmacist donates $2 million to Massachusetts College of Pharmacy and Health Sciences

FDA issues warning on supplements marketed for ED, sexual enhancement

A judge has ruled that a Maine law barring prescribing information from being used for marketing is unconstitutional